Patient-Guide_OnX

Patient Guide References

 

  1. Perez V. The Heart, Interior Heart. Graphic by Barcharts Inc. Boca Raton FL ©2001.; www.barcharts.com; www.quickstudy.com
  2. American Heart Association. Your Heart and How It Works. Graphic by American Heart Association ©2005; www.americanheart.org
  3. Jamieson WRE. Current and advanced prostheses for cardiac valvular replacement and reconstructive surgery. Universal Medical Press, Inc.: San Francisco CA. Surgical Technology International 2002;X:1-29 www.ump.com
  4. Wu ZJ, Gao BZ, Slonin JH, Hwang NHC. Bileaflet mechanical heart valves at low cardiac output. ASAIO J 1996;42(5):M747-M749
  5. Shipkowitz T, Ambrus J, Kurk J, et al. Evaluation technique for bileaflet mechanical valves. J Heart Valve Dis 2002;11:275-82
  6. Linden PA, Cohn LH. Medium-term follow-up of pulmonary autograft aortic valve replacement: technical advances and echocardiographic follow-up. J Heart Valve Dis 2001;10:35- 42
  7. Schmid FX, Keyser A, Wiesenack C, et al. Stentless xenografts and homografts for right ventricular outflow tract reconstruction during the Ross operation. Ann Thorac Surg 2002;74:684-88
  8. Rahimtoola SH. Choice of prosthetic heart valve for adult patients. JACC 2003;41(6):893-904
  9. Girard SE, Miller FA, Orszulak TA, et al. Reoperation for prosthetic aortic valve obstruction in the era of echocardiography: trends in diagnostic testing and comparison with surgical findings. JACC 2001;37(2):579-84
  10. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease. Executive summary. J Heart Valve Dis 1998;7:672-707
  11. Deviri E, Sareli P, Wisenbaugh T, et al. Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management. JACC 1991;17(3):646-50
  12. Teshima H, Hayashida N, Fukunaga S, et al. Usefulness of a multidetector-row computed tomography scanner for detecting pannus formation. Ann Thorac Surg 2004;77:523-26
  13. Aoyagi S, Nishimi M, Kawano H, et al. Obstruction of St. Jude Medical valves in the aortic position. J Thorac Cardiovasc Surg 2000;120(1):142-47
  14. Øvrum E, Tangen G. Acute leaflet arrest in St. Jude Medical Regent aortic valve. J Thorac Cardiovasc Surg 2005;129:1446
  15. Hirsh J, Fuster V, Ansell J, et al. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. JACC 2003;41(9):1633-52
  16. Bristol-Myers Squibb Company. www.bms.com
  17. Körtke H, Körfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 2001;72:44-48
  18. Barmada H, Starr A. Clinical hemolysis with the St. Jude heart valve without paravalvular leak. Medical Progress through Technology 1994;20:191-94
  19. Morishita Y, Arikawa K, Yamashita M, et al. Fatal hemolysis due to unidentified causes following mitral valve replacement with bileaflet tilting disc valve prosthesis. Heart Vessels 1987;3:100-03
  20. Skoularigis J, Essop MR, Skudicky D, et al. Frequency and severity of intravascular hemolysis after left-sided cardiac valve replacement with Medtronic Hall and St. Jude Medical prostheses, and influence of prosthetic type, position, size and number. Am J Cardiol 1993;71:587-91
  21. Mecozzi G, Milano AD, De Carlo M, et al. Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study. J Thorac Cardiovasc Surg 2002; 123:550-56
  22. Akins CW, Hilgenberg AD, Vlahakes GJ, et al. Results of bioprosthetic versus mechanical aortic valve replacement performed with concomitant coronary artery bypass grafting. Ann Thorac Surg 2002;74:1098-106
  23. Jamieson WRE, von Lipinski O, Miyagishima RT, et al. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement. J Thorac Cardiovasc Dis 2005;129:1301-08
  24. Khan S, Trento A, DeRobertis M, et al. Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg 2001;122:257-69
  25. Aagaard J, Tingleff J, Hansen CN, et al. Twelve years’ clinical experience with the CarboMedics prosthetic heart valve. J Hear Valve Dis 2001;10:177-89
  26. Emery RW, Krogh CC, Arom KV, et al. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement. Ann Thorac Surg 2005;79:776-83
  27. Fiane AE, Geiran OR, Svennevig JL. Up to eight years follow-up of 997 patients receiving the CarboMedics prosthetic heart valve. Ann Thorac Surg 1998;66;443-48
  28. Gudbjartsson T, Aranki S, Cohn LH. Mechanical/bioprosthetic mitral valve replacement. In: Cohn LH, Edmunds LH Jr, eds. Cardiac Surgery in the Adult. New York: McGraw-Hill 2003;951-86
  29. Ikonomidis JS, Kratz JM, Crumbley AJ, et al. Twenty-year experience with the St. Jude Medical mechanical valve prosthesis. J Thorac Cardiovasc Surg 2003;126(6):2002-31
  30. Kang CH, Ahn H, Kim KH, et al. Long-term result of 1144 Carbomedics mechanical valve implantations. Ann Thorac Surg 2005;79:1939-44
  31. Li HH, Hahn J, Urbanski P, et al. Intermediate-term results with 1019 Carbomedics aortic valves. Ann Thorac Surg 2001;71:1181-88
  32. Lim KHH, Caputo M, Ascione R, et al. Prospective randomized comparison of CarboMedics and St. Jude Medical bileaflet mechanical heart valve prostheses: an interim report. J Thorac Cardiovasc Surg 2002;123:21-32
  33. Summary of Safety and Effectiveness, On-X Prosthetic Heart Valve, FDA PMA P000037 and P000037/S1, May 30, 2001 and March 6, 2002, European Primary Trial, updated May 31, 2003
  34. Tominaga R, Kurisu K, Ochiai Y, et al. A 10-year experience with the Carbomedics cardiac prosthesis. Ann Thorac Surg 2005;79:784-89
  35. Bach DS, Kon ND, Dumesnil JG, et al. Ten-year outcome after aortic valve replacement with the Freestyle stentless bioprosthesis. Ann Thorac Surg 2005;80:480-87
  36. Cartier PC, Dumesnil JG, Metras J, et al. Clinical and hemodynamic performance of the Freestyle aortic root bioprostheses. Ann Thorac Surg 1999;67:345-51
  37. Corbineau H, De La Tour B, Verhoye JP, et al. Carpentier-Edwards supraannular porcine bioprosthesis in aortic position: 16-year experience. Ann Thorac Surg 2001;71:S228-31
  38. David TE, Ivanov J, Armstrong S, et al. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001;121:268-78
  39. Dellgren G, David TE, Raanani E, et al. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg 2002;124:146-54
  40. Desai ND, Merin O, Cohen GN, et al. Long-term results of aortic valve replacement with the St. Jude Toronto stentless porcine valve. Ann Thorac Surg 2004;78:2076-83
  41. Glower DD, White WD, Hatton AC, et al. Determinants of reoperation after 960 valve replacements with Carpentier-Edwards prostheses. J Thorac Cardiovasc Surg 1994; 107:381-93
  42. Jamieson WRE, Janusz MT, Burr LH, et al. Carpentier-Edwards supraannular porcine bioprosthesis: second-generation prosthesis in aortic valve replacement. Ann Thorac Surg 2001;71:S224-27
  43. Kon ND, Riley RD, Adair SM, et al. Eight-year results of aortic root replacement with the Freestyle stentless porcine aortic root bioprosthesis. Ann Thorac Surg 2002;73:1817-21
  44. Le Tourneau T, Vincentelli A,, Fayad G, et al. Ten-year echocardiographic and clinical follow-up of aortic Carpentier-Edwards pericardial and supraannular prosthesis: a case-match study. Ann Thorac Surg 2002;74:2010-15
  45. Marchand MA, Aupart MR, Norton R, et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg 2001;71:S236-39
  46. Masters RG, Haddad M, Pipe AL, et al. Clinical outcomes with the Hancock II bioprosthetic valve. Ann Thorac Surg 2004;78:832-36
  47. Philips SJ. Searching for the truth: a mechanical or a tissue valve? J Heart Valve Dis 2004;13(Suppl.1):S95-S98
  48. Wheatley DJ. Life quality and expectancy after heart valve replacement. J Heart Valve Dis 2004:13(Suppl 1):S91-S94
  49. Summary of Safety and Effectiveness, St. Jude Medical® Cardiac Valve, FDA PMA P810002, December 17, 1982
  50. St. Jude Medical Physician’s Manual, St. Jude RegentTM Mechanical Heart Valve. St. Paul MN: St. Jude Medical, Inc. 2003
  51. Pelletier LC, Carrier M, Leclerc Y, et al. The Carpentier-Edwards pericardial bioprosthesis: clinical experience with 600 patients. Ann Thorac Surg 1995;60:S297-302
  52. Aupart MR, Neville PH, Hammami S, et al. Carpentier-Edwards pericardial valves in the mitral position: ten-year follow-up. J Thorac Cardiovasc Surg 1997:113:492-98
  53. Piehler J, Blackstone EH, Bailey KR, et al. Reoperation on prosthetic heart valve-patient specific estimation of in-hospital events. J Thorac Cardiovasc Surg 1995;109:30-48
  54. Kirsch M, Nakashima K, Kubota S, et al. The risk of reoperative heart valve procedures in octogenarian patients. J Heart Valve Dis 2004;13:991-96
  55. Banbury MK, Cosgrove DM, Thomas JD, et al. Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg 2002;73: 1460-65
  56. Danton MH, Sarsam MA, Byrne JG, et al. Clinical and hemodynamic performance of the Toronto SPV bioprosthesis. J Heart Valve Dis 2000;9:644-652
  57. Moidl R, Simon P, Wolner E, et al. The On-X Prosthetic Heart Valve at five years. Ann Thorac Surg 2002;74:S1312-17
  58. Williams MA, Crause L, van Riet S. A comparison of mechanical valve performance in a poorly anticoagulated community. J Card Surg 2004;19(5):410-1415
  59. Laczkovics A, Heidt M, Oelert H, et al. Early clinical experience with the On-X Prosthetic Heart Valve. J Heart Valve Dis 2001;10:94-99
  60. Reduced Anticoagulation Clinical Trial of the On-X Prosthetic Heart Valve. Protocol approved by the US Food and Drug Administration January, 2006.
  61. Novoa R, Sanofsky S, Sandhu A. Prevalence of prosthesis-patient mismatch in a community hospital. Presentation at Innovations in Cardiac Surgery 2003 held in conjunction with AATS 2003 in Boston, Massachusetts. Proceedings published by MCRI in Austin, Texas, 2003, 27
  62. Kilian E, Oberhoffer M, Gulbins H, et al. Ten years’ experience in aortic valve replacement with homografts in 389 cases. J Heart Valve Dis 2004;13:554-59
  63. Koolbergen DR, Hazekamp MG, de Heer E, et al. The pathology of fresh and cryopreserved homograft heart valves: an analysis of forty explanted homograft valves. J Thorac Cardiovasc Surg 2002;124:689-97
  64. O’Brien MF, Harrocks S, Stafford EG, et al. The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements. J Heart Valve Dis 2001;10:334-45
  65. Berrebi AJ, Carpentier SM, Phuong PK, et al. Results of up to 9 years of high-temperature-fixed valvular bioprostheses in a young population. Ann Thorac Surg 2001:71:S353-55
  66. Ashour ZA, Shawky HAF, Hussein MH, et al. Outcome of pregnancy in women with mechanical valves. Tex Heart Inst J 2000;27:240-45
  67. Avila WS, Rossi EG, Grinberg M, et al. Influence of pregnancy after bioprosthetic valve replacement in young women: a prospective five-year study. J Heart Valve Dis 11:864-69
  68. De Santo LS, Romano G, Della Corte A, et al. Mitral mechanical replacement in young rheumatic women: analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707 patient-year follow-up. J Thorac Cardiovasc Surg 2004;130(1):13-19
  69. Desmarais R, Golden G, Beynon G. The Coumadin® Cookbook, A Complete Guide to Healthy Meals when taking Coumadin®. 2nd ed. Marsh Publishing Company 1998: Salisbury MD. 442 pp
  70. LaGrange LD, Gott VL, Bokros JC, Ramos MD. Compatibility of carbon and blood. Hegyeli RJ, Editor. PROCEEDINGS, Artificial Heart Program Conference. Washington DC, June 9-13, 1969: pp 47-58

For Patients & General Inquiries
Mark A. Spindler
Manager of Clinical Education
spindler.mark@cryolife.com
512-580-2265

For Product Inquiries
Kellen Moulton
Product Manager
moulton.kellen@cryolife.com
512-580-2291

Contact Us About On-X Heart Valves!

Patient Stories about the On-X Heart Valve

Speak with a clinical consultant:
1-800-438-8285